| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.085 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.086 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |